vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $58.8M, roughly 1.6× CBAK Energy Technology, Inc.). Vericel Corp runs the higher net margin — 25.0% vs -12.5%, a 37.6% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 23.3%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
CBAT vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $92.9M |
| Net Profit | $-7.4M | $23.2M |
| Gross Margin | 7.3% | 78.7% |
| Operating Margin | -13.6% | 24.1% |
| Net Margin | -12.5% | 25.0% |
| Revenue YoY | 131.8% | 23.3% |
| Net Profit YoY | -63.6% | 17.3% |
| EPS (diluted) | $-0.08 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $92.9M | ||
| Q3 25 | $60.9M | $67.5M | ||
| Q2 25 | $40.5M | $63.2M | ||
| Q1 25 | $34.9M | $52.6M | ||
| Q4 24 | $25.4M | $75.4M | ||
| Q3 24 | $44.6M | $57.9M | ||
| Q2 24 | $47.8M | $52.7M | ||
| Q1 24 | $58.8M | $51.3M |
| Q4 25 | $-7.4M | $23.2M | ||
| Q3 25 | $2.7M | $5.1M | ||
| Q2 25 | $-3.1M | $-553.0K | ||
| Q1 25 | $-1.6M | $-11.2M | ||
| Q4 24 | $-4.5M | $19.8M | ||
| Q3 24 | $17.6K | $-901.0K | ||
| Q2 24 | $6.4M | $-4.7M | ||
| Q1 24 | $9.8M | $-3.9M |
| Q4 25 | 7.3% | 78.7% | ||
| Q3 25 | 8.0% | 73.5% | ||
| Q2 25 | 11.0% | 73.7% | ||
| Q1 25 | 13.7% | 69.0% | ||
| Q4 24 | 13.1% | 77.6% | ||
| Q3 24 | 15.6% | 71.9% | ||
| Q2 24 | 26.6% | 69.5% | ||
| Q1 24 | 31.9% | 68.9% |
| Q4 25 | -13.6% | 24.1% | ||
| Q3 25 | -6.6% | 5.1% | ||
| Q2 25 | -8.7% | -3.2% | ||
| Q1 25 | -8.2% | -24.3% | ||
| Q4 24 | -26.0% | 24.5% | ||
| Q3 24 | -1.9% | -4.3% | ||
| Q2 24 | 12.4% | -11.5% | ||
| Q1 24 | 17.4% | -10.7% |
| Q4 25 | -12.5% | 25.0% | ||
| Q3 25 | 4.4% | 7.5% | ||
| Q2 25 | -7.6% | -0.9% | ||
| Q1 25 | -4.5% | -21.4% | ||
| Q4 24 | -17.8% | 26.3% | ||
| Q3 24 | 0.0% | -1.6% | ||
| Q2 24 | 13.5% | -8.9% | ||
| Q1 24 | 16.7% | -7.5% |
| Q4 25 | $-0.08 | $0.46 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $-0.03 | $-0.01 | ||
| Q1 25 | $-0.02 | $-0.23 | ||
| Q4 24 | $-0.05 | $0.40 | ||
| Q3 24 | $0.00 | $-0.02 | ||
| Q2 24 | $0.07 | $-0.10 | ||
| Q1 24 | $0.11 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $137.5M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $354.6M |
| Total Assets | $426.2M | $488.0M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $137.5M | ||
| Q3 25 | $10.5M | $135.4M | ||
| Q2 25 | $45.7M | $116.9M | ||
| Q1 25 | $9.6M | $112.9M | ||
| Q4 24 | $11.0M | $116.2M | ||
| Q3 24 | $24.2M | $101.7M | ||
| Q2 24 | $44.1M | $102.5M | ||
| Q1 24 | $23.8M | $110.6M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $354.6M | ||
| Q3 25 | $121.4M | $321.9M | ||
| Q2 25 | $118.2M | $306.8M | ||
| Q1 25 | $120.8M | $295.5M | ||
| Q4 24 | $121.7M | $292.0M | ||
| Q3 24 | $131.2M | $257.5M | ||
| Q2 24 | $126.6M | $243.0M | ||
| Q1 24 | $120.9M | $233.9M |
| Q4 25 | $426.2M | $488.0M | ||
| Q3 25 | $363.9M | $453.3M | ||
| Q2 25 | $333.1M | $435.6M | ||
| Q1 25 | $311.5M | $424.6M | ||
| Q4 24 | $302.2M | $432.7M | ||
| Q3 24 | $293.5M | $390.4M | ||
| Q2 24 | $279.6M | $376.8M | ||
| Q1 24 | $286.5M | $356.7M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $15.0M |
| Free Cash FlowOCF − Capex | $16.1M | $12.8M |
| FCF MarginFCF / Revenue | 27.3% | 13.8% |
| Capex IntensityCapex / Revenue | 23.4% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $15.0M | ||
| Q3 25 | $14.6M | $22.1M | ||
| Q2 25 | $13.8M | $8.2M | ||
| Q1 25 | $-9.6M | $6.6M | ||
| Q4 24 | $9.6M | $22.2M | ||
| Q3 24 | $19.7M | $10.2M | ||
| Q2 24 | $2.9M | $18.5M | ||
| Q1 24 | $7.4M | $7.2M |
| Q4 25 | $16.1M | $12.8M | ||
| Q3 25 | $6.0M | $19.5M | ||
| Q2 25 | $4.1M | $81.0K | ||
| Q1 25 | $-22.3M | $-7.6M | ||
| Q4 24 | $3.9M | $8.5M | ||
| Q3 24 | $16.5M | $-9.2M | ||
| Q2 24 | $2.5M | $1.8M | ||
| Q1 24 | $-454.0K | $-6.8M |
| Q4 25 | 27.3% | 13.8% | ||
| Q3 25 | 9.9% | 28.8% | ||
| Q2 25 | 10.2% | 0.1% | ||
| Q1 25 | -63.9% | -14.5% | ||
| Q4 24 | 15.5% | 11.2% | ||
| Q3 24 | 37.1% | -15.9% | ||
| Q2 24 | 5.2% | 3.4% | ||
| Q1 24 | -0.8% | -13.3% |
| Q4 25 | 23.4% | 2.4% | ||
| Q3 25 | 14.1% | 3.9% | ||
| Q2 25 | 23.8% | 12.9% | ||
| Q1 25 | 36.3% | 27.0% | ||
| Q4 24 | 22.5% | 18.3% | ||
| Q3 24 | 7.0% | 33.5% | ||
| Q2 24 | 0.9% | 31.8% | ||
| Q1 24 | 13.4% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 5.51× | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
